Anal Carcinoma, Version 2.2012

Featured Updates to the NCCN Guidelines

Restricted access

The workup and management of squamous cell anal carcinoma, which represents the most common histologic form of the disease, are addressed in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Anal Carcinoma. These NCCN Guidelines Insights provide a summary of major discussion points of the 2012 NCCN Anal Carcinoma Panel meeting. In summary, the panel made 4 significant changes to the 2012 NCCN Guidelines for Anal Carcinoma: 1) local radiation therapy was added as an option for the treatment of patients with metastatic disease; 2) multifield technique is now preferred over anteroposterior-posteroanterior (AP-PA) technique for radiation delivery and the AP-PA technique is no longer recommended as the standard of care; 3) PET/CT should now be considered for radiation therapy planning; and 4) a section on risk reduction was added to the discussion section. In addition, the panel discussed the use of PET/CT for the workup of anal canal cancer and decided to maintain the recommendation that it can be considered in this setting. They also discussed the use of PET/CT for the workup of anal margin cancer and for the assessment of treatment response. They reaffirmed their recommendation that PET/CT is not appropriate in these settings.

  • 1

    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:1029.

  • 2

    Johnson LG, Madeleine MM, Newcomer LM. Anal cancer incidence and survival: the Surveillance, Epidemiology, and End Results experience, 1973–2000. Cancer 2004;101:281288.

    • Search Google Scholar
    • Export Citation
  • 3

    Daling JR, Madeleine MM, Johnson LG. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004;101:270280.

    • Search Google Scholar
    • Export Citation
  • 4

    Frisch M, Glimelius B, van den Brule AJ. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997;337:13501358.

  • 5

    Jimenez W, Paszat L, Kupets R. Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario. Gynecol Oncol 2009;114:395398.

    • Search Google Scholar
    • Export Citation
  • 6

    Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000;342:792800.

  • 7

    Sunesen KG, Norgaard M, Thorlacius-Ussing O, Laurberg S. Immunosuppressive disorders and risk of anal squamous cell carcinoma: a nationwide cohort study in Denmark, 1978–2005. Int J Cancer 2010;127:675684.

    • Search Google Scholar
    • Export Citation
  • 8

    Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000;92:15001510.

    • Search Google Scholar
    • Export Citation
  • 9

    Uronis HE, Bendell JC. Anal cancer: an overview. Oncologist 2007;12:524534.

  • 10

    De Vuyst H, Clifford GM, Nascimento MC. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009;124:16261636.

    • Search Google Scholar
    • Export Citation
  • 11

    Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009;124:23752383.

    • Search Google Scholar
    • Export Citation
  • 12

    Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998;177:361367.

    • Search Google Scholar
    • Export Citation
  • 13

    Patel HS, Silver AR, Northover JM. Anal cancer in renal transplant patients. Int J Colorectal Dis 2007;22:15.

  • 14

    Patel P, Hanson DL, Sullivan PS. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med 2008;148:728736.

    • Search Google Scholar
    • Export Citation
  • 15

    Scholefield JH, Castle MT, Watson NF. Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg 2005;92:11331136.

  • 16

    Watson AJ, Smith BB, Whitehead MR. Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg 2006;76:715717.

  • 17

    Berry JM, Palefsky JM, Jay N. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum 2009;52:239247.

    • Search Google Scholar
    • Export Citation
  • 18

    Jay N. Elements of an anal dysplasia screening program. J Assoc Nurses AIDS Care 2011;22:465477.

  • 19

    Park IU, Palefsky JM. Evaluation and management of anal intraepithelial neoplasia in HIV-negative and HIV-positive men who have sex with men. Curr Infect Dis Rep 2010;12:126133.

    • Search Google Scholar
    • Export Citation
  • 20

    Roark R. The need for anal dysplasia screening and treatment programs for HIV-infected men who have sex with men: a review of the literature. J Assoc Nurses AIDS Care 2011;22:433443.

    • Search Google Scholar
    • Export Citation
  • 21

    Scholefield JH, Harris D, Radcliffe A. Guidelines for management of anal intraepithelial neoplasia. Colorectal Dis 2011;13(Suppl 1):310.

  • 22

    Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007;356:19151927.

  • 23

    Dillner J, Kjaer SK, Wheeler CM. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ 2010;341:c3493.

    • Search Google Scholar
    • Export Citation
  • 24

    Garland SM, Hernandez-Avila M, Wheeler CM. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356:19281943.

    • Search Google Scholar
    • Export Citation
  • 25

    Palefsky JM, Giuliano AR, Goldstone S. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011;365:15761585.

    • Search Google Scholar
    • Export Citation
  • 26

    FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010;59:626629.

    • Search Google Scholar
    • Export Citation
  • 27

    Kreimer AR, Gonzalez P, Katki HA. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Lancet Oncol 2011;12:862870.

    • Search Google Scholar
    • Export Citation
  • 28

    Ajani JA, Winter KA, Gunderson LL. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 2008;299:19141921.

    • Search Google Scholar
    • Export Citation
  • 29

    Rosenbaum SJ, Lind T, Antoch G, Bockisch A. False-positive FDG PET uptake—the role of PET/CT. Eur Radiol 2006;16:10541065.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 268 237 19
PDF Downloads 32 30 6
EPUB Downloads 0 0 0